Back to Selection     Print       Date : 31 Aug 2025
Fund Summary
Bandhan Focused Fund Reg (G)
[Equity: Focused]  
 
Fund Details
Fund Type Growth Launch Date 16-Mar-06
Corpus(Cr.) 1919.0 Latest NAV 89.863 As on 12-11-2025
Equity(%) 94.75 52 Week High 91.785
Debt(%) 5.25 52 Week Low 75.133
Others(%) 0.0 Exit Load For units in excess of 10% of the investment, 1% will be charged for redemption within 365 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.08
Scheme Benchmark BSE 500 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Kirthi Jain
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme aims to generate capital appreciation by investing in a concentrated portfolio of equity & equity related instruments of upto 30 stocks.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 32.60%
Top 10 Holdings 52.10%
Top 25 Holdings 92.95%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 24.3
Pharma & Biotech 12.65
Finance & Investments 11.77
Retail 10.06
Software & Services 6.43
Cash 5.25
Technology 3.84
Construction 3.59
Agricultural & Farm Machinery 3.44
Food Beverage & Tobacco 3.23
FMCG 3.06
Chemicals 2.97
Energy 2.64
Petroleum Products 2.52
Telecom 2.26
Textiles 1.99
 
 
 
 
 
Portfolio Metrics
PB Ratio 2.70
PE Ratio 17.89
 
Top 25 Holdings
Holdings Net Asset(%)
POWER FINANCE CORPORATION LTD 8.04
State Bank of India 7.84
HDFC Bank Limited 6.46
ICICI Bank Limited 5.17
Tri Party Repo 5.09
Prestige Estates Projects Limited 4.90
One 97 Communications Limited 3.84
Cholamandalam Financial Holdings Limited 3.73
Larsen & Toubro Limited 3.59
LT Foods Limited 3.44
Infosys Limited 3.37
SOUTH INDIAN BANK LTD 3.28
Jubilant Pharmova Limited 3.19
ITC Limited 3.06
Deepak Fertilisers & Petrochemicals Corp. Ltd. 2.97
Varun Beverages Limited 2.88
NTPC Limited 2.64
Eternal Limited 2.63
MANKIND PHARMA LIMITED 2.58
SIGNATURE GLOBAL (INDIA) LIMITED 2.53
Reliance Industries Limited 2.52
J B Chemicals and Pharma Ltd 2.46
Glenmark Pharmaceuticals Limited 2.29
Bharti Airtel Limited 2.26
Tata Consultancy Services Limited 2.19

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
2.45% 3.64% 7.37% 6.04%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
2.72% 5.90% 4.83% 9.71%
 
Scheme Benchmark [NSE - Nifty 500 TRI]
2.44% 5.83% 6.70% 7.84%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
22.24% 18.69% 17.06% 13.48%
 
 
16.50% 13.41% 16.69% 14.08%
 
 
18.30% 16.12% 19.38% 14.98%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Bandhan Focused Fund Reg (G) 14.07% 0.7336 11.5346% 43.8172 0.1133
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Bandhan Focused Fund Reg (G) 10.8435% 0.0000 -1.0449 20.7984 1.5130
 
Back to Selection